Products

Arboviruses: global threat and local reality

Vector-borne diseases such as dengue, chikungunya, Zika and West Nile fever account for more than 17% of all infectious diseases worldwide [1]. According to the World Health Organization (WHO), over 5.6 billion people live in areas at risk of arboviral infections – that’s more than half of the global population [2]. With over 35 years […]

Products

Seoul virus: When pet rats become a risk

Anyone who has got a pet rat at home knows how intelligent and adaptable these animals are. And they are becoming increasingly popular as pets. However, as with all animals in human care, there is a risk of them transmitting pathogens, such as hantaviruses, to humans. Hantaviruses, which occur worldwide, belong to the group of

Products

Increasing spread of infectious diseases due to climate change

Experts worldwide have identified climate change as the greatest health challenge of the 21st century. There is growing evidence that climatic changes also favour the emergence, recurrence and spread of infectious diseases. However, the full extent of this worrying development is still insufficiently investigated. In a study from 2022, researchers analysed the literature and found

Products

Exotic emerging diseases

Emerging infectious diseases is a term for new infectious diseases in humans that have either newly appeared in a population or have already existed but are rapidly increasing in incidence or geographic range. The term also covers diseases that are caused by novel pathogens. These have developed from bacteria or viruses that were previously harmless

Coronavirus complete serological tests Covid-19 - ELISA CE-marked
Products

EUROIMMUN now offers a complete test package for direct detection of the new coronavirus and antibodies against SARS-CoV-2

Notification EUROIMMUN AG from Lübeck in Germany, a manufacturer of reagents and automated systems for medical laboratory diagnostics, has developed a PCR test for direct virus detection, in addition to the assays for the detection of antibodies against SARS-CoV-2 (ELISA). The new test is a real-time reverse transcriptase PCR used to detect the genetic material

Scroll to Top